POAI Predictive Oncology Inc
24,999
$1.77
$0.04
(2.21%)
| Watchers | 24,999 |
| 52-Wk Low | $1.12 |
| 52-Wk High | $7.12 |
| Market Cap | $7.35M |
| Volume | 147,001.00 |
| 52-Wk High | $7.12 |
| 52-Wk Low | $1.12 |
Q4 2023 Predictive Oncology Inc Earnings Call TranscriptGuruFocus • about 1 month ago
Related Stocks: NAS:POAI...
Share to Feed
Predictive Oncology GAAP EPS of -$3.48, revenue of $1.78M...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Predictive Oncology just reported results for the fourth quarter of 2023.
The post POAI Stock Earnings: Predictive Oncology Reported...
Company to host investor call and webcast on Monday, April 1st, at 8:30am EDTPITTSBURGH, March 28, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging...
PITTSBURGH, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that Raymond F. Vennare, Chief Executive...
Predictive Oncology Inc. (NASDAQ:POAI Get Free Report) saw a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 32,200...
Predictive Oncology Inc. (NASDAQ:POAI Get Free Report)s share price passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $3.15 and...
PITTSBURGH, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that Raymond F. Vennare, Chief Executive...
Predictive Oncology Inc. (NASDAQ:POAI Get Free Report) was the target of a significant decline in short interest in the month of December. As of December 15th, there was short interest...